# Emendo Biotherapeutics

**Source:** https://www.startuphub.ai/startups/emendo-biotherapeutics
**Profile type:** Startup

> Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

## About

Emendo Biotherapeutics is a genome editing company focused on creating novel genetic medicines and cell therapies for patients suffering from severe diseases. Their approach leverages proprietary protein engineering and selection platforms to generate highly specific and potent CRISPR OMNI nucleases, aiming to overcome limitations of existing gene editing tools.

## Key facts

- **Slug:** emendo-biotherapeutics
- **Website:** https://emendobio.com/
- **Location:** Tel Aviv, Israel
- **Founded:** 2015-05-01 00:00:00
- **Employees:** 41
- **Operating status:** Active
- **Total funding:** $61M
- **Sectors / tags:** Healthcare, Genome Editing, CRISPR, Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials, Gene Editing, Genetic Medicine, Cell Therapy
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/emendo-biotheraputics/

## Frequently asked

### What does Emendo Biotherapeutics do?

Emendo Biotherapeutics is a genome editing company focused on creating novel genetic medicines and cell therapies for patients suffering from severe diseases. Their approach leverages proprietary protein engineering and selection platforms to generate highly specific and potent CRISPR OMNI nucleases, aiming to overcome limitations of existing gene editing tools.

### How much funding has Emendo Biotherapeutics raised?

Emendo Biotherapeutics has raised a total of $61M in funding. The most recent round on record is Series B.

### Where is Emendo Biotherapeutics headquartered?

Emendo Biotherapeutics is headquartered in Tel Aviv, Israel.

### When was Emendo Biotherapeutics founded?

Emendo Biotherapeutics was founded in 2015.

### What industry does Emendo Biotherapeutics operate in?

Emendo Biotherapeutics operates in Healthcare, Genome Editing, CRISPR, Biotech, MedTech, HealthTech.

### How many employees does Emendo Biotherapeutics have?

Emendo Biotherapeutics has approximately 41 people on record.

### What is Emendo Biotherapeutics's revenue?

StartupHub estimates Emendo Biotherapeutics's annual revenue at $8.7M (range $4.6M to $25.9M, 64% confidence), based on comparable companies in the sector.

### What is Emendo Biotherapeutics's valuation?

StartupHub estimates Emendo Biotherapeutics's effective valuation at $228.7M (range $152.5M to $366.0M, 10% confidence), based on comparable companies in the sector.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Emendo Biotherapeutics",
          "item": "https://www.startuphub.ai/startups/emendo-biotherapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/emendo-biotherapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/emendo-biotherapeutics",
      "name": "Emendo Biotherapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Emendo Biotherapeutics. Emendo Biotherapeutics is a startup founded in 2015, operating in Healthcare and Genome Editing. Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. Headquartered in Tel Aviv, Israel. The company has approximately 41 employees.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/emendo-biotherapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/emendo-biotherapeutics#organization",
      "name": "Emendo Biotherapeutics",
      "url": "https://emendobio.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/startups/139287.jpeg",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/startups/139287.jpeg",
      "description": "This is the official profile of Emendo Biotherapeutics. Emendo Biotherapeutics is a startup founded in 2015, operating in Healthcare and Genome Editing. Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. Headquartered in Tel Aviv, Israel. The company has approximately 41 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/emendo-biotheraputics/",
        "https://www.startuphub.ai/startups/emendo-biotherapeutics"
      ],
      "foundingDate": "2015-05-01 00:00:00",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 41
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Tel Aviv",
        "addressCountry": "Israel"
      },
      "knowsAbout": [
        "Healthcare",
        "Genome Editing",
        "CRISPR",
        "Biotech",
        "MedTech",
        "HealthTech",
        "Genomics",
        "Drug Discovery",
        "Clinical Trials",
        "Gene Editing",
        "Genetic Medicine",
        "Cell Therapy"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/emendo-biotherapeutics#profile-assessment",
      "name": "Emendo Biotherapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/emendo-biotherapeutics",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/startups/139287.jpeg",
      "category": "Healthcare",
      "description": "This is the official profile of Emendo Biotherapeutics. Emendo Biotherapeutics is a startup founded in 2015, operating in Healthcare and Genome Editing. Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. Headquartered in Tel Aviv, Israel. The company has approximately 41 employees. Agent Readiness score: 39/100. Full audit: https://www.startuphub.ai/startups/emendo-biotherapeutics/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Emendo Biotherapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-01",
        "name": "Emendo Biotherapeutics - Profile Score 63/100",
        "reviewBody": "This is the official profile of Emendo Biotherapeutics. Emendo Biotherapeutics is a startup founded in 2015, operating in Healthcare and Genome Editing. Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. Headquartered in Tel Aviv, Israel. The company has approximately 41 employees. Agent Readiness score: 39/100. Full audit: https://www.startuphub.ai/startups/emendo-biotherapeutics/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 63,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```